These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 4715103)

  • 1. The pharmacist in the care of ambulatory mental health patients.
    Ivey MF
    Am J Hosp Pharm; 1973 Jul; 30(7):599-602. PubMed ID: 4715103
    [No Abstract]   [Full Text] [Related]  

  • 2. Antiparkinson medication in the treatment of extrapyramidal side effects: single of multiple daily doses?
    Neu C; Dimascio A; Demirgian E
    Curr Ther Res Clin Exp; 1972 May; 14(5):246-51. PubMed ID: 4623975
    [No Abstract]   [Full Text] [Related]  

  • 3. [Use in psychiatry of antiparkinson drugs].
    Bourgeois M; Mazaux JM; Imbert D; Daubech MJ; Daulouède JP; Tignol J
    Ann Med Psychol (Paris); 1976 Oct; 2(3):499-510. PubMed ID: 1020859
    [No Abstract]   [Full Text] [Related]  

  • 4. [Delayed-action neuroleptics (sustained-release neuroleptics). Indications, advantages and side effects].
    Predescu V; Nica-Udangiu St
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Neurol Psihiatr Neurochir; 1975; 20(4):287-96. PubMed ID: 1085475
    [No Abstract]   [Full Text] [Related]  

  • 5. Prolonged treatment of psychotic states. (Over 1600 patients treated continuously 3 to 7 years).
    Goldman D
    Dis Nerv Syst; 1968 Mar; 29(3):Suppl:51-7. PubMed ID: 4970486
    [No Abstract]   [Full Text] [Related]  

  • 6. The neuroleptics. 10. Therapeutic problems.
    Barahona-Fernandes HJ; Cazzullo CL; Cocchi A; Denber HC; Freyhan FA; Klerman GL; Köknel O; Levine J; Saarma J; Sarteschi P; Vinar O; Wittenborn JR
    Mod Probl Pharmacopsychiatry; 1970; 5():148-56. PubMed ID: 4949818
    [No Abstract]   [Full Text] [Related]  

  • 7. Ethylbenzatropine for acute neurological and mental side effects after tranquillisers.
    Molcan J; Floreánová L; Polák L
    Act Nerv Super (Praha); 1972; 14(2):97. PubMed ID: 5040183
    [No Abstract]   [Full Text] [Related]  

  • 8. [Prolonged neurologic syndromes due to neuroleptic drugs and their treatment].
    Deniker P; Ginestet D
    Ann Med Interne (Paris); 1972; 123(8):787-9. PubMed ID: 4642195
    [No Abstract]   [Full Text] [Related]  

  • 9. [Evaluation of the anti-anxiety activity of lorazepam in ambulatory patients].
    Terra SO; Bueno JR; Pires LL
    J Bras Psiquiatr; 1971; 20(3):237-47. PubMed ID: 4950635
    [No Abstract]   [Full Text] [Related]  

  • 10. Lack of indication for use of antiparkinson medication. A follow-up study.
    Pecknold JC; Ananth JV; Ban TA; Lehmann HE
    Dis Nerv Syst; 1971 Aug; 32(8):538-41. PubMed ID: 5094160
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical pharmacists as allied health care providers to psychiatric patients.
    Gray DR; Namikas EA; Sax MJ; Brinkman J; Cheung A; Gordon M; Parker AG; Welch PH
    Contemp Pharm Pract; 1979; 2(3):108-16. PubMed ID: 10242843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prescriptions of psychiatrists working in Prague policlinics.
    Vinar O; Zámecník L
    Act Nerv Super (Praha); 1971; 13(3):235-7. PubMed ID: 4398847
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effects of neuroleptic withdrawal on the drug-induced extrapyramidal syndrome of chronic schizophrenia].
    Elie R; Gagnon MA; Gauthier R; Jéquier JC
    Union Med Can; 1975 Jun; 104(6):909-14. PubMed ID: 772906
    [No Abstract]   [Full Text] [Related]  

  • 14. Extended clinical roles for the pharmacist in psychiatric care.
    Coleman JH; Evans RL; Rosenbluth SA
    Am J Hosp Pharm; 1973 Dec; 30(12):1143-6. PubMed ID: 4763220
    [No Abstract]   [Full Text] [Related]  

  • 15. Prevention and management of tardive dyskinesia.
    Crane GE
    Am J Psychiatry; 1972 Oct; 129(4):466-7. PubMed ID: 5071149
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison of pharmacist and physician prescribing for psychiatric inpatients.
    Stimmel GL; McGhan WF; Wincor MZ; Deandrea DM
    Am J Hosp Pharm; 1982 Sep; 39(9):1483-6. PubMed ID: 6127948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An attempt to classify neuroleptic drugs on the basis of short-term clinical comparative studies.
    Rodová A; Náhunek K; Svestka J
    Act Nerv Super (Praha); 1974 Aug; 16(3):169-70. PubMed ID: 4609274
    [No Abstract]   [Full Text] [Related]  

  • 18. [Indications and results in the use of 19.552 RP].
    López-Ibor Aliño JM; López-Ibor Aliño JJ
    Actas Luso Esp Neurol Psiquiatr; 1971; 30(1):17-28. PubMed ID: 4945618
    [No Abstract]   [Full Text] [Related]  

  • 19. Basic principles in the use of antipsychotic agents.
    Mason AS
    Hosp Community Psychiatry; 1973 Dec; 24(12):825-9. PubMed ID: 4148176
    [No Abstract]   [Full Text] [Related]  

  • 20. Evaluating the long-term need for antiparkinson drugs by chronic schizophrenics.
    Klett CJ; Caffey E
    Arch Gen Psychiatry; 1972 Apr; 26(4):374-9. PubMed ID: 4552131
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.